V

Vaxart
D

VXRT

0.42750
USD
-0.01
(-2.53%)
مغلق
حجم التداول
10,574
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
97,565,312
أصول ذات صلة
BNTX
BNTX
1.570
(1.45%)
109.800 USD
I
INO
-0.71500
(-33.49%)
1.42000 USD
MRNA
MRNA
0.195
(0.64%)
30.480 USD
N
NVAX
0.04000
(0.59%)
6.79000 USD
PFE
PFE
0.110
(0.43%)
25.440 USD
المزيد
الأخبار المقالات

العنوان: Vaxart

القطاع: Healthcare
الصناعة: Biotechnology
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines based on its Vector Adjuvant Antigen Standardized Technology to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.